Table 3. Concentrations and activities of selected haemostatic parameters in BrCa patients depending on menopausal status.
| Coagulation assays (units) | Pre-menopausal BrCa patients | Post-menopausal BrCa patients | P-values |
|---|---|---|---|
| n=27 | n=58 | ||
| TF activity (pM) | 15.20/11.62/25.06 | 12.96/10.73/28.26 | 0.6760 |
| TF concentration (pg/ml) | 539.93/400.86/626.30 | 542.92/401.72/727.53 | 0.7010 |
| TF/TFPI activity ratio | 12.59/7.76/25.41 | 10.72/7.30/25.97 | 0.5963 |
| TFPI activity (U/ml) | 1.34/0.94/1.51 | 1.31/1.13/1.52 | 0.6724 |
| TFPI concentration (ng/ml) | 40.68/30.24/59.60 | 46.92/39.80/60.34 | 0.0853 |
| TF/TFPI concentration ratio | 12.67/8.43/19.52 | 10.66/8.77/14.72 | 0.4226 |
| t-PA concentration (ng/ml) | 4.23/2.62/5.30 | 5.70/4.24/7.21 | 0.0092 |
| PAI-1 concentration (ng/ml) | 37.20/27.87/76.01 | 38.23/29.20/44.79 | 0.3215 |
Significant differences are denoted by bold P-values. The underlined P-value represents closeness to statistical signifcance.